Osteopenia Completed Phase Trials for Alendronic acid (DB00630)

Also known as: Osteopaenia / Bone loss

IndicationStatusPhase
DBCOND0015922 (Osteopenia)CompletedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00145977Texture Analysis for Postmenopausal OsteoporosisTreatment